Terms: = Colorectal cancer AND PTPN11, CFC, Q06124, 5781, ENSG00000179295, SHP2, MGC14433, SHP-2, BPTP3, PTP-1D, SH-PTP3, NS1, SH-PTP2, PTP2C AND Prognosis
11 results:
1. High expression of shp2 predicts a promising prognosis in colorectal cancer.
Liu X; Li M; Chen L; Wen F; Zheng S; Ge W
Indian J Pathol Microbiol; 2024; 67(1):29-35. PubMed ID: 38358185
[TBL] [Abstract] [Full Text] [Related]
2. RNA-Seq Analysis Reveals Altered Expression of Cell Adhesion-Related Genes Following PZR Knockout in Lung cancer Cells.
Fu Y; Li G; Fu X; Xing S; Zhao ZJ
Appl Biochem Biotechnol; 2024 Apr; 196(4):2122-2136. PubMed ID: 37470934
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic significance of shp2 (ptpn11) expression in solid tumors: A meta-analysis.
Zhou J; Guo H; Zhang Y; Liu H; Dou Q
PLoS One; 2022; 17(1):e0262931. PubMed ID: 35061863
[TBL] [Abstract] [Full Text] [Related]
4. Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer.
Yuan Y; Qi G; Shen H; Guo A; Cao F; Zhu Y; Xiao C; Chang W; Zheng S
Int J Cancer; 2019 Apr; 144(7):1584-1595. PubMed ID: 29987896
[TBL] [Abstract] [Full Text] [Related]
5. Inflammatory genes are novel prognostic biomarkers for colorectal cancer.
Jiang H; Dong L; Gong F; Gu Y; Zhang H; Fan D; Sun Z
Int J Mol Med; 2018 Jul; 42(1):368-380. PubMed ID: 29693170
[TBL] [Abstract] [Full Text] [Related]
6. BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines.
Herr R; Halbach S; Heizmann M; Busch H; Boerries M; Brummer T
Oncogene; 2018 Mar; 37(12):1576-1593. PubMed ID: 29326440
[TBL] [Abstract] [Full Text] [Related]
7. shp2 associates with nuclear localization of STAT3: significance in progression and prognosis of colorectal cancer.
Huang Y; Wang J; Cao F; Jiang H; Li A; Li J; Qiu L; Shen H; Chang W; Zhou C; Pan Y; Lu Y
Sci Rep; 2017 Dec; 7(1):17597. PubMed ID: 29242509
[TBL] [Abstract] [Full Text] [Related]
8. Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target.
Ye L; Lin ST; Mi YS; Liu Y; Ma Y; Sun HM; Peng ZH; Fan JW
Tumour Biol; 2016 Nov; 37(11):14585-14594. PubMed ID: 27614686
[TBL] [Abstract] [Full Text] [Related]
9. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
Chang W; Gao X; Han Y; Du Y; Liu Q; Wang L; Tan X; Zhang Q; Liu Y; Zhu Y; Yu Y; Fan X; Zhang H; Zhou W; Wang J; Fu C; Cao G
Gut; 2014 Sep; 63(9):1457-67. PubMed ID: 24173294
[TBL] [Abstract] [Full Text] [Related]
10. SPARCL1, shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer.
Yu SJ; Yu JK; Ge WT; Hu HG; Yuan Y; Zheng S
World J Gastroenterol; 2011 Apr; 17(15):2028-36. PubMed ID: 21528083
[TBL] [Abstract] [Full Text] [Related]
11. CXCL10 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Xu Y; Cai S
Mol Biol Rep; 2010 Jul; 37(6):3029-36. PubMed ID: 19821051
[TBL] [Abstract] [Full Text] [Related]
